Novartis | Créances Commerciales



Trade Debtors Changement Date
AbbVie USD 10.92B 553M 2024-12
Amgen USD 8.13B 1.35B 2025-03
AstraZeneca USD 14.82B 16M 2025-03
Bausch Health Companies USD 2.07B 68M 2025-03
Biogen USD 2B 127.7M 2025-03
Bristol-Myers Squibb USD 14.59B 162M 2025-03
Canopy Growth CAD 49.06M 7.2M 2024-12
Corcept Therapeutics USD 61.82M 7.84M 2025-03
Drreddys Laboratories INR 111.49B 8.65B 2024-12
Eli Lilly USD 14B 727.8M 2025-03
Gilead Sciences USD 4.39B 32M 2025-03
GlaxoSmithKline GBP 7.5B 176M 2025-03
Glaxosmithkline GBP 7.32B 542M 2024-12
Indivior 272M 16M 2025-03
J&J USD 16.02B 1.18B 2025-03
Merck USD 11.57B 452M 2025-03
Novartis USD 9B 854M 2024-12
Novartis USD 7.56B 594M 2024-12
Pacira USD 104.74M 8.56M 2025-03
Perrigo USD 716.8M 30.6M 2025-03
Pfizer USD 14.74B 32M 2025-03
Prestige Brands USD 194.29M 27.02M 2025-03
Roche Holding CHF 13.46B 984M 2024-12
Sanofi 447M 10.18B 2025-03
Sanofi 10.63B 1.82B 2024-12
Supernus Pharmaceuticals USD 142.08M 3.33M 2024-12
Zoetis USD 1.36B 45M 2025-03



Novartis Créances Commerciales - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.